292 related articles for article (PubMed ID: 1827659)
1. The dualistic mode of action of the vasodilator drug, nicorandil, differentiated by glibenclamide in 86Rb flux studies in rabbit isolated vascular smooth muscle.
Kreye VA; Lenz T; Theiss U
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):70-5. PubMed ID: 1827659
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of nicorandil by 86Rb efflux and isometric vasorelaxation studies in vascular smooth muscle.
Kreye VA; Lenz T; Pfründer D; Theiss U
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S8-12. PubMed ID: 1282181
[TBL] [Abstract][Full Text] [Related]
3. Effects of the K+ channel blocker tedisamil on 86Rb efflux induced by cromakalim, high potassium and noradrenaline, and on mechanical tension in rabbit isolated vascular smooth muscle.
Kreye VA; Pfründer D; Theiss U
Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb; 345(2):238-43. PubMed ID: 1570026
[TBL] [Abstract][Full Text] [Related]
4. Some degree of overlap exists between the K(+)-channels opened by cromakalim and those opened by minoxidil sulphate in rat isolated aorta.
Bray K; Quast U
Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):351-9. PubMed ID: 1961260
[TBL] [Abstract][Full Text] [Related]
5. Differential antagonism by glibenclamide of the relaxant effects of cromakalim, pinacidil and nicorandil on canine large coronary arteries.
Satoh K; Yamada H; Taira N
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):76-82. PubMed ID: 1827660
[TBL] [Abstract][Full Text] [Related]
6. Evidence that pinacidil may promote the opening of ATP-sensitive K+ channels yet inhibit the opening of Ca2(+)-activated K+ channels in K(+)-contracted canine mesenteric artery.
Masuzawa K; Matsuda T; Asano M
Br J Pharmacol; 1990 May; 100(1):143-9. PubMed ID: 2115387
[TBL] [Abstract][Full Text] [Related]
7. Possible involvement of ATP-sensitive K+ channels in the relaxant response of dog middle cerebral artery to cromakalim.
Masuzawa K; Asano M; Matsuda T; Imaizumi Y; Watanabe M
J Pharmacol Exp Ther; 1990 Nov; 255(2):818-25. PubMed ID: 2123008
[TBL] [Abstract][Full Text] [Related]
8. Comparison of effects of cromakalim and pinacidil on mechanical activity and 86Rb efflux in dog coronary arteries.
Masuzawa K; Asano M; Matsuda T; Imaizumi Y; Watanabe M
J Pharmacol Exp Ther; 1990 May; 253(2):586-93. PubMed ID: 2160002
[TBL] [Abstract][Full Text] [Related]
9. Potassium channel opening properties of a novel compound, NIP-121, cromakalim and nicorandil in rat aorta and portal vein.
Masuda Y; Arakawa C; Yamashita T; Miyajima M; Shigenobu K; Kasuya Y; Tanaka S
Eur J Pharmacol; 1991 Apr; 195(3):323-31. PubMed ID: 1831135
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic calcium and the relaxation of canine coronary arterial smooth muscle produced by cromakalim, pinacidil and nicorandil.
Yanagisawa T; Teshigawara T; Taira N
Br J Pharmacol; 1990 Sep; 101(1):157-65. PubMed ID: 2149290
[TBL] [Abstract][Full Text] [Related]
11. Analysis of relaxation and repolarization mechanisms of nicorandil in rat mesenteric artery.
Fujiwara T; Angus JA
Br J Pharmacol; 1996 Dec; 119(8):1549-56. PubMed ID: 8982500
[TBL] [Abstract][Full Text] [Related]
12. The diverse effects of cromakalim on tension and 86Rb efflux in canine arterial smooth muscle.
Masuzawa K; Matsuda T; Asano M
Br J Pharmacol; 1991 May; 103(1):1033-40. PubMed ID: 1878743
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.
Quast U; Cook NS
J Pharmacol Exp Ther; 1989 Jul; 250(1):261-71. PubMed ID: 2501478
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological interaction experiments differentiate between glibenclamide-sensitive K+ channels and cyclic GMP as components of vasodilation by nicorandil.
Holzmann S; Kukovetz WR; Braida C; Pöch G
Eur J Pharmacol; 1992 Apr; 215(1):1-7. PubMed ID: 1325362
[TBL] [Abstract][Full Text] [Related]
15. Effects of the novel potassium channel opener, UR-8225, on contractile responses in rat isolated smooth muscle.
Perez-Vizcaino F; Casis O; Rodriguez R; Gomez LA; Garcia Rafanell J; Tamargo J
Br J Pharmacol; 1993 Nov; 110(3):1165-71. PubMed ID: 8298804
[TBL] [Abstract][Full Text] [Related]
16. Effects of nicorandil on cytosolic calcium concentrations and on tension development in the rabbit femoral artery.
Abe S; Nishimura J; Nakamura M; Kanaide H
J Pharmacol Exp Ther; 1994 Feb; 268(2):762-71. PubMed ID: 8113988
[TBL] [Abstract][Full Text] [Related]
17. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
Nielsen-Kudsk JE
Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
[TBL] [Abstract][Full Text] [Related]
18. Dissimilarity in the mechanisms of action of KRN2391, nicorandil and cromakalim in canine renal artery.
Kasai H; Fukata Y; Harada K; Fukushima H; Ogawa N
J Pharm Pharmacol; 1993 Mar; 45(3):222-4. PubMed ID: 8097782
[TBL] [Abstract][Full Text] [Related]
19. K+ channel opening mediates the vasorelaxant effects of nicorandil in the intact vascular system.
Cavero I; Pratz J; Mondot S
Z Kardiol; 1991; 80 Suppl 7():35-41. PubMed ID: 1838848
[TBL] [Abstract][Full Text] [Related]
20. Vasodilating actions of cromakalim in resting and contracting states of carotid arteries from spontaneously hypertensive rats.
Asano M; Masuzawa-Ito K; Matsuda T
Eur J Pharmacol; 1994 Sep; 263(1-2):121-31. PubMed ID: 7529710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
